Company: ENTXW
Filing Date: 2025-05-14
Form Type: PRE 14A
Source: 0001178913-25-001794
Chunk: 56

Company: Entera Bio Ltd.
Filing Date: 2025-05-14
Form: PRE 14A
Chunk 56
---
 columns, the fair value or change in fair value, as applicable, of the equity award adjustments included in such calculations was computed in accordance with FASB ASC Topic 718. The valuation assumptions used to calculate such fair values did not materially differ from those disclosed at the time of grant.The following table details the applicable adjustments that were made to the determine “compensation actually paid” (all amounts are averages for Non-PEO NEOs). |

32 The below figures are represented in thousands.

|                                                                                              |     | PEO |  2024 |   |     |   | 2023 |   |     | Non-PEO NEO Average | 2024 |   |     |   | 2023 |   |
|:---------------------------------------------------------------------------------------------|:----|:----|------:|:--|:----|:--|-----:|:--|:----|:--------------------|-----:|:--|:----|:--|-----:|:--|
| Summary Compensation Table Total                                                             |     | $   | 1,149 |   |     | $ |  950 |   |     | $                   |  485 |   |     | $ |  385 |   |
| -the fair value of equity awards granted that are reported in the Summary Compensation Table |     |     |  (742 | ) |     |   | (532 | ) |     |                     | (246 | ) |     |   | (141 | ) |
| + Fair value as of the end of all awards granted during the covered fiscal year that are     
 outstanding and unvested at the end of the covered year                                      |     |     |   360 |   |     |   |  126 |   |     |                     |  245 |   |     |   |   72 |   |
| +/- Change in fair value as of the end of the covered fiscal year (from the end of the prior 
 fiscal year) of any awards granted in any prior fiscal year that are outstanding and         
 unvested as of the end of the covered fiscal year                                            |     |     |   863 |   |     |   |  (81 | ) |     |                     |  222 |   |     |   |   (9 | ) |
| Fair Value as of Vesting Date of Equity Awards Granted and Vested in the Year                |     |     |   112 |   |     |   |    -